IRIS
MORISCO, FILOMENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.380
AS - Asia 2.248
EU - Europa 1.990
AF - Africa 79
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 3
SA - Sud America 3
Totale 8.710
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.295
SG - Singapore 1.139
IT - Italia 649
CN - Cina 571
HK - Hong Kong 409
UA - Ucraina 307
FI - Finlandia 255
NL - Olanda 223
SE - Svezia 133
IE - Irlanda 132
DE - Germania 131
VN - Vietnam 91
CA - Canada 80
CI - Costa d'Avorio 71
GB - Regno Unito 71
RU - Federazione Russa 44
IN - India 19
ES - Italia 13
FR - Francia 11
EU - Europa 7
LT - Lituania 7
TR - Turchia 7
ET - Etiopia 5
MX - Messico 5
PS - Palestinian Territory 4
AU - Australia 3
BE - Belgio 3
CZ - Repubblica Ceca 3
PH - Filippine 3
AT - Austria 2
BR - Brasile 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CH - Svizzera 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
LB - Libano 1
NG - Nigeria 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 8.710
Salva come PNG Salva come JPEG
Città #
Singapore 966
Chandler 658
Hong Kong 407
Santa Clara 393
Millbury 310
Jacksonville 283
Princeton 256
Amsterdam 213
Boston 198
Ashburn 193
Nanjing 181
Des Moines 116
Naples 116
Napoli 94
Beijing 90
Dong Ket 88
Wilmington 76
Ottawa 69
Nanchang 67
Lawrence 54
Seattle 46
Shenyang 41
Hebei 40
Boardman 30
Norwalk 29
Dublin 26
Jiaxing 26
Kronberg 25
Washington 20
Changsha 19
Helsinki 18
Kunming 18
Tianjin 18
Woodbridge 17
Council Bluffs 14
Falls Church 14
Houston 14
Orange 14
Rome 14
London 13
Redwood City 13
Milan 12
Bologna 11
Dearborn 10
Frankfurt am Main 10
Hangzhou 10
Afragola 9
Moscow 8
Toronto 8
Redmond 7
Shanghai 7
Teulada 7
Ann Arbor 6
Cagliari 6
Caivano 6
The Dalles 6
Catanzaro 5
Changchun 5
Lanzhou 5
Mexico City 5
Pomigliano D'arco 5
Pune 5
Baronissi 4
Campobasso 4
Caserta 4
Dallas 4
Fairfield 4
Florence 4
Munich 4
Nuremberg 4
Schoenwalde 4
Springfield 4
Bari 3
Brussels 3
Falkenstein 3
Ho Chi Minh City 3
Ischia 3
Lappeenranta 3
Legnaro 3
Los Angeles 3
Pamplona 3
Pozzuoli 3
Salerno 3
Sorrento 3
Verona 3
Walnut 3
Acquaviva Delle Fonti 2
Andover 2
Aversa 2
Casalecchio di Reno 2
Castellammare Di Stabia 2
Collegeville 2
Freiburg im Breisgau 2
Gualtieri 2
Guardiagrele 2
Indiana 2
Istanbul 2
Maddaloni 2
Manila 2
Melito Di Napoli 2
Totale 5.560
Salva come PNG Salva come JPEG
Nome #
CIRANAD (Centro Interuniversitario per Ricerche su Alimenti Nutrizione ed Apparato Digerente) 95
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 85
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 71
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study 70
Reactivation of hepatitis B or C in patients with IBD receiving immunosuppressive drugs. A multicentre study 65
Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis 64
Innate and acquired immune systemin patients developing interferon-alpha-related autoimmune thyroiditis: a prospective study. 60
Efficacy of loco-regional ablation therapy of HCC in a population of liver transplanted patients 60
Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for Lymphoma 57
A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C 56
Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study. 54
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania 54
Tomato-based Functional Food as Interferon Adjuvant in HCV Eradication Therapy 53
Alfa-glutathione transferases in HCV-related chronic hepatitis: a new predictive index of response to inteferon therapy? 50
Apple polyphenol extracts prevent damage to human gastric epithelial cells in vitro and to rat gastric mucosa in vivo 50
BIOCHEMICAL MARKERS OF OXIDATIVE STRESS IN PERIPHERAL LYMPHOCYTES OF PATIENTS WITH HCV-RELATED LIVER DESEASES. 48
Lack of evidence that adherence to standard of care therapy improves survival in subjects with hepatocellular carcinoma in clinical practice 48
Eradication of HCV in Renal Transplant Recipients and Its Effects on Quality of Life 48
Variation in genes encoding for interferon λ-3 and λ-4 in the prediction of HCV-1 treatment-induced viral clearance 47
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 47
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 46
No differences of response to telaprevir based therapy in cirrhotic and non cirrhotic patients with RVR: a real life data from South Italy. Hepatology 2014; 60 (S1): 695A-696A. Abstract. 1018 46
Decaffeinated coffee consumption induces expression of tight junction proteins in high fat diet fed rats 46
Coffee and Intestinal Permeability in a Mice Model of Non-Alcoholic Fatty Liver Disease 46
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 45
Alfa-glutathione transferases in HCV-related chronic hepatitis: a new predictive index of response to interferon therapy? 45
A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alpha-interferon 45
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 45
AISF position paper on liver disease and pregnancy 45
Concomitant Interferon-alfa and chemotherapy in hepatitis C and colorectal cancer: a case report 44
Effect of immunosuppressive therapy on patients with inflammatory bowel diseases and hepatitis B or C virus infection. 43
Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease. 43
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 43
Prevalence of and risk factors for HBV infection in a metropolitan Southern Italian area: Evidence for the effectiveness of universal Hepatitis B vaccination 43
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 43
Long-term antibody persistence and immune memory to hepatitis B virus in adult celiac patients vaccinated as adolescents. 42
alimentazione e NAFLD 42
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection. 42
Dietary supplementation of vitamin D prevents the development of western diet-induced metabolic, hepatic and cardiovascular abnormalities in rats 42
Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma 42
Development of a tomato-based food for special medical purpose as therapy adjuvant for patients with HCV infection 41
Coffee and liver health 41
Prevalence and risk factors of HCV infection in a metropolitan area in southern Italy: Tail of a cohort infected in past decades 41
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort 41
Decaffeinated Coffee Reduces Body Weight Gain in Rats Fed With a Hfd by Modulating Intestinal Gpr41 and CCK Expression 40
Use of Telemedicine for chronic liver disease at a single care center during the COVID-19 pandemic: Prospective observational study 40
Dietary antioxidant compounds and liver health 39
5th Probiotics & Prebiotics New Foods 39
Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins 39
Analysis of breath by proton transfer reaction time of flight mass spectrometry in rats with steatohepatitis induced by high-fat diet. 39
Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection 39
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions 39
Metabolic disorders across hepatocellular carcinoma in Italy 39
Liver stiffness assessment by transient elastography suggests high prevalence of liver involvement in common variable immunodeficiency 39
Effect of Red Wine Polyphenols on the Expression of Transthyretin in Murine Choroid Plexus 38
HCV infection and hepatocellular carcinoma in cirrhotics: What is the linkage? 37
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patientes with chronic viral hepatitis 37
Usefulness of a liver biopsy in the evaluation of patients with elevated ALT values and serological markers of hepatitis viral infection 37
Alimenti ed alcol: interazione, sommazione, riduzione del danno? 37
Prevalence of hepatitis C virus infection in the household contacts of patients with HCV-related chronic liver disease. 37
Garlic extract prevents CCl(4)-induced liver fibrosis in rats: The role of tissue transglutaminase. 37
alimenti, epatotossicità ed epatoprotezione 37
Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasis. 37
L'avvento degli inibitori delle proteasi nella terapia dell'infezione da epatite C: Reazioni avverse dermatologiche 37
Circulating SCCA–IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients 37
POLY(ADPribosyl)ATION IN LYMPHOCYTES FROM HUMAN PERIPHERAL BLOOD OF PATIENTS WITH HCV INFECTION RELATED HEPATIC PATHOLOGIES. 36
5. 25(OH)D3 and bone metabolism in non cirrhotic, non cholestatic chronic viral hepatitis 36
HCV infection in symptom-free patients. 36
Hepatitis B virus infection and immunosuppressive therapy in patients with inflammatory bowel disease. 36
alimenti nella patogenesi e nella terapia delle epatiti croniche. 36
An a priori prediction model of response to peginterferon plus ribavirin dual therapy in na?ve patients with genotype 1 chronic hepatitis C. 36
Impact of telaprevir in HCV patients with cirrhosis and RVR: real-life data from Boceprevir or Telaprevir based "triple therapy" experience in southern Italy 36
Corrigendum to "Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV" [J Hepatol 68 (2018) 33-41] 36
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 36
studio multicentrico, retrospettivo, osservazionale, sulla popolazione italiana di soggetti affetti da epatite cronica C che ha fallito l'eliminazione dell'HCV-RNA dopo terapia combinata con PEG-IFN e ribavirina: studio NADIR 35
Functional intestinal disorders: how to improve diagnosis and treatment in general practice 35
Soggetti con patologia tiroidea in compenso farmacologico. 35
Long-term safety of anti-TNF-? in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients. 35
Vitamin D levels and chronic hepatitis C 35
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis 35
Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice 35
Plasma phospholipid dysregulation in patients with cystathionine-β synthase deficiency 35
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 34
Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C. 34
The addiction of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism. 34
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 34
Long-term observation of HCV-positive patients with normal ALT values: persistence of a clinically healthy state. 34
Application of PTR-TOF-MS to investigate metabolites in exhaled breath of patients affected by coeliac disease under gluten free diet 34
Osteoporosis across chronic liver disease 34
Impact of Diabetes on Outcomes of Sorafenib Therapy for Hepatocellular Carcinoma 34
Hepatitis C Virus Clearance in Older Adults 34
Metabolic-associated fatty liver disease (MAFLD) in coeliac disease 34
Role of sex in liver tumor occurrence and clinical outcomes: a comprehensive review 33
Decaffeinated coffee reduces gut leakiness in rats fed with high-fat diet. The role of Occludin and Zonulin-1 33
HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome 33
Platelets and hepatocellular cancer: Bridging the bench to the clinics 33
Incidence of HCC recurrence after DAA treatment for HCV in a multicentre Italian cohort study 33
Awareness of individual goals, preferences, and priorities of persons with severe congenital haemophilia A for a tailored shared decision-making approach to liver-directed gene therapy. A practical guideline 32
Foods and liver health 32
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 32
Totale 4.229
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.686
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.686
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020272 0 0 0 0 0 0 10 8 13 45 91 105
2020/2021851 22 56 101 71 99 131 75 8 86 32 76 94
2021/20221.337 24 6 14 2 1 21 15 52 125 61 281 735
2022/20231.632 321 90 17 115 230 181 12 133 221 223 75 14
2023/20241.298 36 245 194 78 40 119 9 134 18 26 270 129
2024/20252.250 459 623 19 72 207 391 479 0 0 0 0 0
Totale 9.088